Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acumen Pharmaceuticals, Inc. (ABOS) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acumen Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1576885.
Total stock buying since 2021: $111,355,997.
Total stock sales since 2021: $564,293.
Total stock option exercises since 2021: $45,058.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 90,630 | $167,006 | 0 | $0 |
| 2024 | 0 | $0 | 34,332 | $121,683 | 0 | $0 |
| 2023 | 5,161,290 | $39,999,997 | 41,949 | $275,604 | 41,949 | $40,061 |
| 2021 | 4,491,250 | $71,356,000 | 0 | $0 | 1,118 | $4,997 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-01 | 0 | $0 | 90,630 | $167,006 | 0 | $0 |
| 2024-01 | 0 | $0 | 34,332 | $121,683 | 0 | $0 |
| 2023-08 | 0 | $0 | 41,949 | $275,604 | 41,949 | $40,061 |
| 2023-07 | 5,161,290 | $39,999,997 | 0 | $0 | 0 | $0 |
| 2021-11 | 0 | $0 | 0 | $0 | 1,118 | $4,997 |
| 2021-07 | 4,491,250 | $71,356,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-03 | Barton Russell (Chief Operating Officer) | Sale | 7,636 | 1.86 | 14,225 |
| 2025-01-03 | Siemers Eric (Chief Medical Officer) | Sale | 10,859 | 1.85 | 20,045 |
| 2025-01-03 | Oconnell Daniel Joseph (Chief Executive Officer) | Sale | 47,778 | 1.84 | 87,863 |
| 2025-01-03 | Zuga Matt (CFO & Chief Business Officer) | Sale | 13,235 | 1.84 | 24,365 |
| 2025-01-03 | Meisner Derek M (Chief Legal Officer & Corp Sec) | Sale | 11,122 | 1.84 | 20,508 |
| 2024-01-19 | Oconnell Daniel Joseph (President and CEO) | Sale | 15,200 | 3.47 | 52,759 |
| 2024-01-19 | Meisner Derek M (Chief Legal Officer & Corp Sec) | Sale | 8,933 | 3.48 | 31,051 |
| 2024-01-18 | Barton Russell (Chief Operating Officer) | Sale | 2,833 | 3.73 | 10,555 |
| 2024-01-18 | Siemers Eric (Chief Medical Officer) | Sale | 3,124 | 3.71 | 11,602 |
| 2024-01-18 | Zuga Matt (CFO & Chief Business Officer) | Sale | 4,242 | 3.71 | 15,716 |
| 2023-08-17 | Ives Jeffrey L. (Director) | Sale | 41,949 | 6.57 | 275,604 |
| 2023-08-17 | Ives Jeffrey L. (Director) | Option Ex | 41,949 | .95 | 40,061 |
| 2023-07-21 | Shah Rajeev M. | Buy | 5,161,290 | 7.75 | 39,999,997 |
| 2021-11-30 | Oconnell Daniel Joseph (President and CEO) | Option Ex | 1,118 | 4.47 | 4,997 |
| 2021-07-06 | Sands Frank M. (10% Owner) | Buy | 450,000 | 14.88 | 6,696,000 |
| 2021-07-06 | Fountain Nathan B (Director) | Buy | 6,250 | 16.00 | 100,000 |
| 2021-07-06 | Hardie Robert D. (10% Owner) | Buy | 1,062,500 | 16.00 | 17,000,000 |
| 2021-07-06 | Stalfort John A Iii (Director) | Buy | 35,000 | 16.00 | 560,000 |
| 2021-07-06 | Shah Rajeev M. | Buy | 1,875,000 | 16.00 | 30,000,000 |
| 2021-07-06 | Manning Paul B (10% Owner) | Buy | 312,500 | 16.00 | 5,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ABOS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acumen Pharmaceuticals, Inc. (symbol ABOS, CIK number 1576885) see the Securities and Exchange Commission (SEC) website.